Library Home | Reset filters
Select one or more filter options and click search below.
Reset filters
AUTHOR(S) Robert Cohen; Marion Ashman; Muhamed-Kheir Taha (et al.)
AUTHOR(S) Tracie O. Afifi; Samantha Salmon; Tamara Taillieu (et al.)
The success in ending the COVID-19 pandemic rests partly on the mass uptake of the COVID-19 vaccine. Little work has been done to understand vaccine willingness among older adolescents and young adults. This is important since this age group may be less likely to adhere to public health guidelines.This article aims to understand willingness of getting a vaccine and reasons for vaccine hesitancy among a sample of older adolescents and young adults.
AUTHOR(S) Taito Kitano; Hirosato Aoki
AUTHOR(S) Erdem Gönüllü; Ahmet Soysal; Serkan Atıcı (et al.)
AUTHOR(S) Serkan Catma; Diana Reindl
AUTHOR(S) Maria Angela Sculli; Gloria Formoso; Laura Sciacca
AUTHOR(S) Mariangela F. Silveira; Cristian T. Tonial; Ana Goretti K. Maranhão (et al.)
There is widespread concern that disruption to health services during the COVID-19 pandemic has led to declines in immunization coverage among young children, but there is limited information on the magnitude of such impact. High immunization coverage is essential for reducing the risk of vaccine preventable diseases.This study used data from two nationwide sources covering the whole of Brazil. Data from the Information System of the National Immunization Program (SIPNI) on the monthly number of vaccine doses administered to young children were analyzed. The second source was a survey in 133 large cities in the 27 states in the country, carried out from August 24–27. Respondents answered a question on whether children under the age of three years had missed any scheduled vaccinations during the pandemic, and available vaccination cards were photographed for later examination.
AUTHOR(S) Stephen Obaro
AUTHOR(S) J.-P. Michel; J. Goldberg
AUTHOR(S) Ilenia Mappa; Maria Luviso; Flavia Adalgisa Distefano (et al.)
The use of Coronavirus 2 (SARS-CoV-2) vaccine in pregnant women is controversial and still not performed in Italy. Our objective was to evaluate the propensity of a population of Italian women to receive the vaccine and its psychological impact. A prospective, observational study was performed on pregnant women attending Ospedale Cristo Re Università Roma TorVergata. A multi-section questionnaire was sent to each included woman on the first day of available SARS-CoV-2 vaccination. Part-A was finalized to acquire maternal characteristics and to test the women’s perception of vaccinations in pregnancy and their fear-induced by vaccines. Part-B included the State-Trait-Anxiety-Inventory (STAI) a validated test for scoring trait anxiety (basal anxiety, STAI-T) and state anxiety (STAI-S). An abnormal value of STAI was considered when ≥40. Comparisons of maternal variables were performed according to their vaccine attitude.
AUTHOR(S) Tamera Coyne-Beasley; Samantha V. Hill; Gregory Zimet (et al.)
AUTHOR(S) Jean-Louis Excler; Lois Privor-Dumm; Jerome H. Kim
Vaccines developed in high-income countries have been enormously successful in reducing the global burden of infectious diseases, saving perhaps 2.5 million lives per year, but even for successful cases, like the rotavirus vaccine, global implementation may take a decade or more. For unincentivized vaccines, the delays are even more profound, as both the supply of a vaccine from developing country manufacturers and vaccine demand from countries with the high disease burdens have to be generated in order for impact to be manifest. A number of poverty-associated infectious diseases, whose burden is greatest in low-income and middle-income countries, would benefit from appropriate levels of support for vaccine development such as Group A Streptococcus, invasive non-typhoid salmonella, schistosomiasis, shigella, to name a few. With COVID-19 vaccines we will hopefully be able to provide novel vaccine technology to all countries through a unique collaborative effort, the COVAX facility, led by the World Health Organization (WHO), Gavi, and the Coalition for Epidemic Preparedness Innovations (CEPI). Whether this effort can deliver vaccine to all its participating countries remains to be seen, but this ambitious effort to develop, manufacture, distribute, and vaccinate 60–80% of the world’s population will hopefully be a lasting legacy of COVID-19.
AUTHOR(S) Luigi Carbone; Ilenia Mappa; Angelo Sirico (et al.)
UNICEF Innocenti's Children and COVID-19 Library is a database collecting research from around the world on COVID-19 and its impacts on children and adolescents.
Subscribe to updates on new research about COVID-19 & children
Check our quarterly thematic digests on children and COVID-19
COVID-19 & Children: Rapid Research Response
